QHSLab, Inc. (USAQ): EBITDA
$222.0K
Year ended 2025-12-31
$154.7K
Trailing 12 months to 2026-06-30
| Period ended | EBITDA | Change YoY | Source filing |
|---|---|---|---|
| 2025-12-31 | $222.0K | -37.0% | 2026-03-30, From 2025-01-01 |
| 2024-12-31 | $352.3K | n/m | 2026-03-30, From 2024-01-01 |
| 2023-12-31 | -$93.6K | n/m | 2025-03-28, From 2023-01-01 |
| 2022-12-31 | -$432.6K | n/m | 2024-03-27, From 2022-01-01 |
| 2021-12-31 | -$466.2K | n/a | 2023-03-29, From 2021-01-01 |
EBITDA at similar companies
| Company | Year ended | EBITDA | Change YoY |
|---|---|---|---|
| QHSLab, Inc. (USAQ) | 2025-12-31 | $222.0K | -37.0% |
| Femasys Inc (FEMY) | 2025-12-31 | -$17.25M | n/m |
| Vycor Medical Inc (VYCO) | 2025-12-31 | $93.4K | +85.4% |
| Tenon Medical, Inc. (TNON) | 2025-12-31 | -$12.53M | n/m |
| Intelligent Bio Solutions Inc. (INBS) | 2026-06-30 | -$11.44M | n/m |
| EBR Systems, Inc. (NONE.) | 2025-12-31 | -$45.68M | n/m |
| Lucid Diagnostics Inc. (LUCD) | 2025-12-31 | -$48.77M | n/m |
| Picard Medical, Inc. (PMI) | 2025-12-31 | -$13.09M | n/m |
| Cerenome, Inc. (CNSY) | 2025-12-31 | -$14.85M | n/m |
Compare USAQ, FEMY, VYCO, TNON side by side · Screen every company in Surgical & Medical Instruments & Apparatus ↗